Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Bilateral Breast Carcinoma × Epothilones × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 6 Recurrent Uterine Corpus Sarcoma 1 Neoplasms 1 Neoplasm Metastasis 1 Endometrial Adenocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Bilateral Breast Carcinoma 1 Adult Solid Neoplasm 1

Interventions

ixabepilone 1 Standard of Care 1 Practice Guidelines as Topic 1 Epothilones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00877500 2025-11-10

Ixabepilone in Treating Participants With Significant Residual Disease of HER2/Neu Negative Invasive Breast Cancer After Systemic Therapy

M.D. Anderson Cancer Center

Phase 2 Active not recruiting

Bilateral Breast Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡